Direction
Buy
Sell
Types
LMT Order
Price
QTY
Amount
--
INRX Intrinsic Medicine
0.0000.0000.00%
Close
02/03 09:30 ET
High
0.000
Open
0.000
Turnover
0.00
Low
0.000
Pre Close
0.000
Volume
0.00
Intraday
5D
1D
1W
1M
1Q
1Y
Price Forecast
No Data
News
Comment
Intrinsic Medicine and Phoenix Biotech Acquisition Corp. Mutually Agree to Terminate Business Combination Agreement
SEATTLE, Dec. 06, 2022 (GLOBE NEWSWIRE) -- Intrinsic Medicine, Inc. (Intrinsic), a therapeutics company leveraging human milk biology to transform Gut-Brain Axis (GBA) and inflammatory disorders, and Phoenix Biotech
Human Milk Drug Developer Intrinsic Medicine to Merge With SPAC Phoenix Biotech
Phoenix Biotech to Take Intrinsic Medicine Public in SPAC Deal
11:39 AM EDT, 10/31/2022 (MT Newswires) -- Phoenix Biotech Acquisition (PBAX), a blank-check company, and Intrinsic Medicine said Monday they have agreed to merge in a deal that would take Intrinsic p
Intrinsic Medicine, Phoenix Biotech Acquisition Enter Merger Agreement
Phoenix Biotech Acquisition Transaction Reflects Pre-Money Equity Value of $136M for Intrinsic Medicine >PBAX
Phoenix Biotech Acquisition Transaction Reflects Pre-Money Equity Value of $136M for Intrinsic Medicine >PBAX
Press Release: Intrinsic Medicine and Phoenix -3-
proceedings that may be instituted against PBAX, Intrinsic or any of their respective directors or officers, following the announcement of the proposed business combination; (xiii) the amount of redem
Phoenix Biotech Acquisition, Intrinsic Medicine Combined Co to Be Listed on Nasdaq Under Ticker INRX
Phoenix Biotech Acquisition, Intrinsic Medicine Combined Co to Be Listed on Nasdaq Under Ticker INRX
Press Release: Intrinsic Medicine and Phoenix -2-
Intrinsic Medicine, Inc. is a preclinical-stage therapeutics company leveraging synthetic biology-manufactured human milk oligosaccharides (HMOs), as new medicines to treat large patient populations u
Intrinsic Medicine and Phoenix Biotech Acquisition in Merger Agreement to Create Public Co Leveraging Human Milk Biology to Treat Gut-Brain Axis Disorders
Intrinsic Medicine and Phoenix Biotech Acquisition in Merger Agreement to Create Public Co Leveraging Human Milk Biology to Treat Gut-Brain Axis Disorders
Intrinsic Medicine Files to Withdraw Planned IPO
By Stephen Nakrosis Intrinsic Medicine Inc. filed a request with the U.S. Securities and Exchange Commission to withdraw its planned initial public offering. In the filing, the company said it has d
